Amniotic fluid alpha2-macroglobulin and the antenatal diagnosis of spina bifida and anencephaly

2008 ◽  
Vol 8 (4) ◽  
pp. 297-301 ◽  
Author(s):  
D. J. H. Brock
1975 ◽  
Vol 12 (2) ◽  
pp. 135-137 ◽  
Author(s):  
G R Sutherland ◽  
D J Brock ◽  
J B Scrimgeour

The Lancet ◽  
1974 ◽  
Vol 303 (7855) ◽  
pp. 429-433 ◽  
Author(s):  
R. Harris ◽  
R.F. Jennison ◽  
A.J. Barson ◽  
K.M. Laurence ◽  
E. Ruoslahti ◽  
...  

The Lancet ◽  
1973 ◽  
Vol 302 (7828) ◽  
pp. 522-525 ◽  
Author(s):  
LindseyD. Allan ◽  
Ian Donald ◽  
M.A. Ferguson-Smith ◽  
ElizabethM. Sweet ◽  
A.A.M. Gibson

The Lancet ◽  
1973 ◽  
Vol 301 (7813) ◽  
pp. 1187 ◽  
Author(s):  
J. Lorber ◽  
C.R. Stewart ◽  
A. Milford Ward

1981 ◽  
Vol 27 (10) ◽  
pp. 1658-1660 ◽  
Author(s):  
P K Buamah ◽  
P Taylor ◽  
A M Ward

Abstract Concanavalin A nonreactive alpha-fetoprotein was determined in samples of amniotic fluid from 16 abnormal pregnancies complicated by anencephaly (7), open spina bifida (6), intra-uterine death (1), anencephaly with exomphalos (1), or open spina bifida with exomphalos (1), and in amniotic fluid from 50 normal pregnancies with gestational age between 13 and 24 weeks. In all 16 cases with fetal malformations, the proportion of nonreactive alpha-fetoprotein was significantly decreased (median 5.3%) as compared with amniotic fluid from pregnancies with a normal outcome (median 39.7%). The results confirm that this measurement is useful in the diagnosis of neural tube defects, especially when the concentration of alpha-fetoprotein in amniotic fluid is normal or only slightly above normal and gestational age is uncertain.


Sign in / Sign up

Export Citation Format

Share Document